Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

METforMIN: Metformin Administration for the Minimization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration

NCT02684578 is registered in ClinicalTrials.gov with University of California, San Francisco as lead sponsor.

NCT NCT02684578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02684578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
METforMIN: Metformin Administration for the Minimization of Geographic Atrophy Progression in Patients With Age-related Macular Degeneration
Lead sponsor
University of California, San Francisco
Phase
Phase 2
Overall status
Completed
Start date
April 30, 2016
Completion date
October 31, 2022
Enrollment
66 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, dry macular degeneration, geographic atrophy, macular degeneration, age-related